Driehaus Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-612,387
| Closed | -$3.12M | – | 463 |
|
2024
Q3 | $3.12M | Sell |
612,387
-83,670
| -12% | -$426K | 0.03% | 292 |
|
2024
Q2 | $4.95M | Sell |
696,057
-115,623
| -14% | -$822K | 0.05% | 259 |
|
2024
Q1 | $2.22M | Hold |
811,680
| – | – | 0.02% | 304 |
|
2023
Q4 | $2.19M | Hold |
811,680
| – | – | 0.03% | 294 |
|
2023
Q3 | $2.13M | Buy |
811,680
+1,087
| +0.1% | +$2.86K | 0.03% | 303 |
|
2023
Q2 | $2.27M | Buy |
810,593
+136,909
| +20% | +$383K | 0.03% | 296 |
|
2023
Q1 | $1.95M | Buy |
673,684
+121,742
| +22% | +$353K | 0.03% | 318 |
|
2022
Q4 | $2.03M | Buy |
551,942
+203,371
| +58% | +$746K | 0.03% | 293 |
|
2022
Q3 | $1.13M | Buy |
+348,571
| New | +$1.13M | 0.02% | 304 |
|